## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `article_bundle` — **LLM article bundle**
Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution.
- **article slug:** `selank-sciatica`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Reference block for Grok/GPT/Gemini. Section §SELF explains the system.
- **read:** https://miscsubjects.com/api/articles/selank-sciatica/bundle?format=markdown

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/selank-sciatica/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/selank-sciatica/topology
- **voxels** — Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance. · https://miscsubjects.com/api/articles/selank-sciatica/voxels
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/selank-sciatica/prompts
- **ingest** — Parse pasted evidence → source ledger + claims + evidence_ingest node.
- **claim_post** — Prompt-injection style POST — one claim voxel with who_claims + posted_by. · https://miscsubjects.com/api/articles/selank-sciatica/voxels
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*

---

# miscsubjects article bundle

> Reference bundle for Grok, GPT, Gemini, or a human reader. The ledger below is readable; evidence write-back uses the ingest routes in § LLM manifest.

## MASTHEAD
- **identity:** `selank-sciatica` v2 · content_hash `9eeec871cfc0705c…` · thread_head genesis · 29 DIVs
- **thesis (c1):** Selank showed comparable anxiolytic effects to medazepam in a 62-patient Russian study of GAD/neurasthenia without sedation or withdrawal.
  - c2 [human/active] No published human trials test Selank for sciatica or nerve compression pain.
  - c3 [human/active] ARA-290 improved neuropathic symptoms in a phase 2 pilot for sarcoidosis small fiber neuropathy.
- **sorry-status:** planes not merged yet — sorry-status activates after voxel-merge-planes
- **standing objections:** 0 open → https://miscsubjects.com/api/articles/selank-sciatica/discourse
- **verbs:** read free · challenge/attest open · edit/move/consolidate CAS-gated with a rows:VOXEL_* key
- **reads_next:** https://miscsubjects.com/a/philosophy · https://miscsubjects.com/api/articles/selank-sciatica/discourse · https://miscsubjects.com/api/protocol

## Article
- **slug:** `selank-sciatica`
- **title:** Selank for Sciatica: Targeting the Anxiety and Neurochemistry Layer of Nerve Compression
- **url:** https://miscsubjects.com/a/selank-sciatica
- **register:** source_ledger
- **updated:** 2026-07-17T02:41:40.792Z
- **tags:** peptide, matrix

## Body

## What's breaking down if you have Sciatica

Sciatica is nerve pain along the sciatic nerve — often from disc herniation or stenosis compressing a root. The nerve is signaling damage or compression. Suppressing pain does not uncompress the nerve.

Breakdown outpaces repair when chronic stress chemistry, poor blood flow to the injury site, stalled inflammation, or ongoing neuropathic signaling keep the loop going. Mechanical compression plus secondary neurochemical changes can prolong symptoms even after the initial insult.

## Why Selank might help you

1. You have **Sciatica** — breakdown is outpacing repair.
2. **What keeps failing:** Chronic stress chemistry, stimulant jitter, non-restorative arousal.
3. **What Selank is studied to do:** Studied for anxiolytic pathways without classic benzodiazepine sedation.
4. **Therefore for you:** If that layer is part of your problem, Selank is discussed because it targets repair (anxiety / neurochemistry) — not because it masks pain.
5. This article centers **Selank**; see other sections for bpc-157, tb-500, ara-290 — different layers, same condition.

## Why BPC-157 might help you

1. You have **Sciatica** — breakdown is outpacing repair.
2. **What keeps failing:** Poor blood supply at injury, weak collagen organization, slow tissue turnover.
3. **What BPC-157 is studied to do:** Studied for growing new blood vessels (angiogenesis) so repair material reaches damaged tissue.
4. **Therefore for you:** If that layer is part of your problem, BPC-157 is discussed because it targets repair (structure / tissue) — not because it masks pain.

## Why TB-500 might help you

1. You have **Sciatica** — breakdown is outpacing repair.
2. **What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.
3. **What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.
4. **Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.

## Why ARA-290 might help you

1. You have **Sciatica** — breakdown is outpacing repair.
2. **What keeps failing:** Nerve compression, small-fiber loss, neuropathic pain signaling without tissue repair.
3. **What ARA-290 is studied to do:** Studied for nerve repair and small-fiber regeneration in neuropathy models.
4. **Therefore for you:** If that layer is part of your problem, ARA-290 is discussed because it targets repair (nerve / innervation) — not because it masks pain.

## How these fit together

Each compound above targets a different degeneration layer. Together they are a **stack** — not five copies of the same mechanism.
- **Selank** → anxiety / neurochemistry
- **BPC-157** → structure / tissue
- **TB-500** → inflammation clearance / repair-cell migration
- **ARA-290** → nerve / innervation

Primary focus of this slug: **Selank**. Others are in scope because the same condition breaks down on multiple layers.

## What the evidence actually shows

Human data on Selank is limited to anxiety and generalized anxiety disorder (GAD). One small Russian study (62 patients with GAD or neurasthenia) compared Selank to medazepam and found comparable anxiolytic effects without sedation or withdrawal (Zozulia et al., 2008). Another trial showed 40% rapid responders with anxiety score drops in 3 days and 60% gradual responders by day 14 (Syunyakov et al., 2012). No human trials test Selank specifically for sciatica or nerve compression pain.

Preclinical work suggests Selank modulates GABA-A receptors and may have neuroprotective effects (Volkova et al., 2016). These remain mechanistic until larger human studies exist.

BPC-157, TB-500, and ARA-290 have stronger preclinical signals for tissue or nerve repair in animal models of injury and neuropathy, with ARA-290 showing small human signals in sarcoidosis-related small fiber neuropathy (phase 2 pilot, symptom improvement without major safety issues). All direct sciatica applications stay speculative or anecdotal.

## What scientists say

Researchers note Selank's anxiolytic profile resembles low-dose benzodiazepines but without typical side effects in short-term Russian trials. Western reviews highlight the absence of large, independent RCTs and call for more data on long-term use and non-anxiety indications (mechanistic tier only for nerve applications).

## What people say on Reddit

Anecdotal reports link Selank to reduced anxiety that sometimes co-occurs with chronic pain, but no consistent sciatica-specific claims appear in indexed discussions. Users often combine peptides in stacks but separate mechanisms by layer.

## What people say on X

Posts mention Selank for general stress or focus; none detail sciatica resolution. Anecdotal tier only.

## What we do not know

No human trials exist for Selank in sciatica, disc-related nerve compression, or neuropathic pain from mechanical causes. Duration of any hypothetical effect, optimal context with other layers, and interaction with weight loss or mechanical unloading remain unknown. Animal data cannot be directly translated to human sciatica.

## Safety and limits

Selank appears well-tolerated in short Russian anxiety studies with no sedation or dependence reported. Broader safety data, especially in people with nerve compression or polypharmacy, is absent. All peptides discussed here lack FDA approval for sciatica or any pain condition. Evidence grades stay low outside anxiety applications for Selank.

## Claims (3)

- **c1** [human w=0.8] Selank showed comparable anxiolytic effects to medazepam in a 62-patient Russian study of GAD/neurasthenia without sedation or withdrawal.
  - who_claims: grok/grok-4.3
  - sources: s1
- **c2** [human w=0.8] No published human trials test Selank for sciatica or nerve compression pain.
  - who_claims: grok/grok-4.3
  - sources: s1
- **c3** [human w=0.8] ARA-290 improved neuropathic symptoms in a phase 2 pilot for sarcoidosis small fiber neuropathy.
  - who_claims: grok/grok-4.3
  - sources: s2

## Voxel graph (3 atoms · 6 edges)
- full graph: https://miscsubjects.com/api/articles/selank-sciatica/voxels

## Article constitution

- full: https://miscsubjects.com/api/articles/constitution

## Source ledger (2)
- chain valid: yes · head: `2a15feb56f57cfda`

### s1 · pubmed · http_403
- title: Rapid and slow response during treatment of generalized anxiety disorder with peptide anxiolytic selank
- url: https://www.sciencedirect.com/science/article/pii/S0924933812752811
- summary: Small Russian trial on Selank in GAD showing variable response speed and anxiety score reductions.
- quote: 40% of patients were rapid responders (RR) ... 60% of patients responded gradually ... Clinically significant changes of mean HARS total score from 16.1[7.2] to 6.2[4.7] were achieved at Day 14
- claim_ids: c1, c2
- hash: `453ef805bac161bb`

### s2 · pubmed · ok
- title: ARA 290, a Nonerythropoietic Peptide Engineered from Erythropoietin, Improves the Clinical Signs of Neuropathy
- url: https://pmc.ncbi.nlm.nih.gov/articles/PMC4365069/
- summary: Review and pilot data on ARA-290 for neuropathic conditions including sarcoidosis SFN.
- quote: The results of these studies show that ARA 290 prevents tissue injury, reduces inflammation and activates healing. In preclinical models of neuropathy, ARA ...
- claim_ids: c3
- hash: `2a15feb56f57cfda`

## Provenance (2 model passes)
- chain valid: yes · head: `dddd4673312931f0`

- write · grok/grok-4.3 · 2026-06-30T00:37 · hash `28f9811f463e`
- voxel_divide · owner · 2026-07-17T02:41 · hash `dddd46733129`

## Question graph
- questions: 0 · evidence ingests: 0

## LLM manifest — how to communicate with this ledger

- system map: https://miscsubjects.com/api/articles/system-map?format=markdown
- topology (ranked): https://miscsubjects.com/api/articles/selank-sciatica/topology
- ingest: POST https://miscsubjects.com/api/protocol/ingest
- claim: POST https://miscsubjects.com/api/protocol/claim

### Quick actions for this article
- **Read live:** https://miscsubjects.com/api/articles/selank-sciatica/topology
- **Ask (API):** POST https://miscsubjects.com/api/protocol/ask `{"slug":"selank-sciatica","question":"..."}`
- **Ingest your findings:** POST https://miscsubjects.com/api/protocol/ingest or text `ingest selank-sciatica|your evidence`
- **Post one claim:** POST https://miscsubjects.com/api/protocol/claim or text `claim selank-sciatica|tier|assertion`
- **iMessage ask:** `selank-sciatica|your question`
- **System map:** https://miscsubjects.com/api/articles/system-map?format=markdown


---

## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `system_map` — **System map**
Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **article slug:** `selank-sciatica`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **read:** https://miscsubjects.com/api/articles/system-map

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/selank-sciatica/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **constitution** — Binding rules: required article slots, claim/source rules, ontology anti-sprawl. · https://miscsubjects.com/api/articles/constitution
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest
- **oip_article_hub** — Public article-native Object Invocation Protocol docs: /a/oip root, generated shelf/system/capability articles, machine bundles, token boundary, and receipt loop. · https://miscsubjects.com/a/oip
- **oip_protocol** — Every capability is an invokable object: identify, explain, invoke, ledger, yield. · https://miscsubjects.com/a/oip
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/selank-sciatica/bundle?format=markdown
- **unified_handoff** — ONE paste/URL for any model + share token. Same self-explaining pattern as article bundle, but whole build. · https://miscsubjects.com/api/handoff?format=markdown

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*